Hana Must SPAC 2
SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. In addition, The compa… Read more
Hana Must SPAC 2 - Asset Resilience Ratio
Hana Must SPAC 2 (208370) has an Asset Resilience Ratio of 18.07% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2024)
This chart shows how Hana Must SPAC 2's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Hana Must SPAC 2's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩12.80 Billion | 18.07% |
| Total Liquid Assets | ₩12.80 Billion | 18.07% |
Asset Resilience Insights
- Good Liquidity Position: Hana Must SPAC 2 maintains a healthy 18.07% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Hana Must SPAC 2 Industry Peers by Asset Resilience Ratio
Compare Hana Must SPAC 2's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
|
Osang Healthcare Co.,Ltd
KQ:036220 |
Medical Devices | 9.34% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
Annual Asset Resilience Ratio for Hana Must SPAC 2 (2015–2024)
The table below shows the annual Asset Resilience Ratio data for Hana Must SPAC 2.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 37.15% | ₩26.09 Billion | ₩70.22 Billion | +0.74pp |
| 2023-12-31 | 36.41% | ₩24.28 Billion | ₩66.68 Billion | +20.76pp |
| 2022-12-31 | 15.65% | ₩7.06 Billion | ₩45.11 Billion | -14.71pp |
| 2021-12-31 | 30.36% | ₩14.87 Billion | ₩48.98 Billion | +0.14pp |
| 2020-12-31 | 30.22% | ₩13.64 Billion | ₩45.14 Billion | +2.75pp |
| 2019-12-31 | 27.48% | ₩12.94 Billion | ₩47.11 Billion | +24.01pp |
| 2018-12-31 | 3.46% | ₩1.43 Billion | ₩41.26 Billion | -2.55pp |
| 2017-12-31 | 6.01% | ₩3.29 Billion | ₩54.70 Billion | -4.36pp |
| 2016-12-31 | 10.37% | ₩4.71 Billion | ₩45.48 Billion | +10.33pp |
| 2015-12-31 | 0.03% | ₩16.50 Million | ₩47.25 Billion | -- |